Shares of Auris Medical Holding Ag EARS, a development-stage biopharmaceutical company, were trading higher by more than 20 percent at $7.17 late Wednesday morning.
Auris Medical's stock is now trading higher by over 40 percent over the past five trading days and are higher by more than 107 percent over the past month.
Related Link: Auris Medical Shares Up 50% Since Breaking Above $3.50 Level Last Week
Auris Medical's Investor Relation page shows no press releases for 2016. In fact, the most recent press release is dated November 13, 2015.
An EDGAR Search for Auris Medical also reveals no SEC-related releases in 2016. The most recent release, a 6-K document, is dated November 12, 2015.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
